Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02266797Phase 3Terminated
A Phase 3 trial of dexamethasone in dysphagia, sponsored by NYU Langone Health. Started Nov 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02266797.